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Development of fast, sensitive, and accurate diagnostic tests is key to controlling infectious diseases. [1] [2] [3] By enabling early diagnosis and treatment, such tests would not only help rapidly identify sources of infection, but would prevent further disease transmission, and reduce the risk of patients developing long-term complications. [ 2 ] The detection of pathogens (bacteria, parasites, fungi, viruses) in clinical specimens, however, has continued to present signifi cant technical challenges, namely because a) specimens often have a complex composition (e.g., blood, tissue), b) sample sizes are often limited, and c) specimens may contain very few pathogens ( e.g. , early disease stages). [4] [5] [6] [7] Magnetic sensing, a technique in which pathogens are labeled with magnetic nanoparticles (MNPs), is uniquely well suited for addressing these challenges. [8] [9] [10] [11] [12] The inherently negligible magnetic background of biological samples enables highly sensitive measurements to be obtained without the need of sample purifi cation. Sample loss prior to measurement is thus minimized and the assay procedure signifi cantly simplifi ed for clinical use. [ 13 , 14 ] Furthermore, magnetic sensors can be easily miniaturized and integrated onto low-cost chips for portable use in clinical settings.
We herein present a new magnetic sensor platform for bacterial detection, which combines the benefi ts of both magnetic measurements and single-cell detection accuracy. In this approach, target bacteria are fi rst labeled with molecularspecifi c MNPs, which are subsequently detected by miniaturized Hall ( µ Hall) sensors. In previous work, we used a prototype µ Hall system to detect mammalian cells ( > 10 µ m in diameter) under fl ow conditions. [ 10 ] Adapting the µ Hall technology to bacterial detection, however, was challenging due to the much smaller size of bacteria ( ∼ 1 µ m). We addressed this problem in two ways: 1) by implementing a new microfl uidic system, which could reliably stream individual bacteria to the sensor surface; and 2) by employing bacterial labeling techniques based on bioorthogonal nanoagents to achieve effi cient and maximal MNP-loading on bacterial targets. [ 13 ] We subsequently validated the developed platform by performing bacterial counts and by detecting Gram-positive bacteria in unprocessed samples.
The µ Hall platform offers several key advantages that enable sensitive detection of pathogens in clinical samples. Because the chip can detect individual pathogens, it is able to ignore not only unbound MNPs but also other cells with inadvertantly attached MNPs. Consequently, the chip is insensitive to non-specifi c labeling and requires no washing steps to remove excess reagents. Additionally, the entire measurement is performed on a single microfl uidic chip format, which eliminates the need for laboratory infrastructure and trained personnel. The assay could be adapted to differentiate a variety of other bacterial species by changing the affi nity ligands. With such capacities, the µ Hall platform thus represents a comprehensive and universal diagnostic platform with potentially broad clinical applications in resource-limited, point-of-care settings. To obtain effi cient MNP-loading on target bacteria, a twostep bioorthogonal labeling method was employed. In this strategy, bacterial targets were fi rst labeled with affi nity ligands modifi ed with trans -cyclooctene (TCO), and MNPs modifi ed with 1,2,4,5-tetrazine (Tz) were then applied. MNPs were thus coupled to the labeled bacterial targets via a cycloaddition reaction between Tz and TCO. [ 15 , 16 ] The method is fast, modular, and can be applied to a variety of different bacterial species using a generic MNP for labeling. Additionally, this method has been shown to maximize MNP binding onto targets, [ 17 , 18 ] due to the smaller size of affi nity ligand-TCO conjugates enabling their better access to the targets, and the ability of high-dosage treatments. Indeed, compared to using direct ligand-MNP conjugates, this two-step method results in much higher ( > 600%) MNP loading onto target cells. [ 13 ] Figure We adapted the µ Hall system for robust bacterial detection. The device has a hybrid microfl uidic/semiconductor chip structure, consisting of a microfabricated sensor and a hydrodynamic fl ow-focusing fl uidic channel ( Figure 2 a ). An external magnetic fi eld ( B 0 ∼ 0.5 T), provided by a small neodymium magnet ( ∼ 1 cm 3 ; attached below the chip), was used to fully magnetize the MNPs. The design of this sensor was based on our initial µ Hall prototype (see SI Methods). [ 10 ] In the current device, eight Hall elements, each with an active area of 8 × 8 µ m 2 , were laid out in an overlapping 2 × 4 array (Figure 2 b) . This geometry enabled more accurate bacterial counting, since it ensured that each bacterium passed over at least two µ Hall elements. It was then possible to enhance the detection accuracy further by averaging the Hall voltages from all eight sensors. The mean Hall voltage (〈 V H 〉) was thus shown to be proportional to the total magnetic moment ( m ) of a single passing magnetic object, and independent of its size. [ 10 ] Compared to mammalian cancer cells, however, bacteria are assumed to have an approximately 100-fold lower m , due to their smaller surface area (diameter ∼ 1 µ m) than mammalian cells (diameter ∼ 10 µ m). To compensate for this loss in m , we devised a way to bring bacteria nearer to the Hall sensors. Given that V H is proportional to ∼ d − 3 , where d is the distance between the center of a bacterium and the Hall sensor, bringing the bacteria closer to the sensors considerably boosts the signal-to-noise ratio (SNR; Figure 2 c). Indeed, our numerical simulation (see SI Methods) showed that the V H was > 1000-fold larger for a bacterium placed on the sensor surface ( d = 0.5 µ m) than for a bacterium placed at the center of the microfl uidic channel ( d = 7.5 µ m).
To stream individual bacteria near to the Hall sensors, we used a two-stage fl ow focusing structure. [ 19 ] Cells were (Figure 2 d) until the sample fl ow could be confi ned within 2 µ m above the sensor surface. The fi nal structure measured 200 µ m wide and 15 µ m high, and could operate under a fl ow rate of up to 2 ml/hour. Moreover, the use of hydrodynamic focusing allowed the physical channel to be much larger than bacteria, which in turn helped lower the fl uidic resistance and reduce the risk of channel clogging. Cellconfi nement could be controlled by adjusting the relative fl ow rates of the lateral and vertical sheaths (Figure 2 e) . We tested this design by detecting MNP-labeled S. aureus in-fl ow. With the use of fl ow-focusing, we were able to observe a distinct V H peak (SNR ∼ 50) from a single bacterium (Figure 2 f) . The fl ight time of the bacterium over the sensor was 20 µ seconds, and the estimated fl ow speed was ∼ 1 m/second. Without the use of fl ow focusing, however, the Hall voltage level fell below the noise fl oor of the device (2 µ V).
We next evaluated the analytical capacity of the µ Hall system by comparing µ Hall measurements with those from fl ow cytometry, for which bacterial samples were prepared by labeling S. aureus with fl uorescent MNPs. The measured V H distribution (from N = 5,000 bacteria) obtained by the µ Hall system was found to correspond well with measurements by fl ow cytometry ( Figure 3 a) and thus confi rmed the accurate detection of bacterial magnetic moments by the µ Hall system. Importantly, because the V H histogram obtained by the µ Hall system was positioned well above the noise fl oor of the device, it ensured that all bacteria in the sample would be counted. Indeed, when we used samples with known bacterial concentrations, we obtained excellent agreement with expected bacterial counts ( R 2 > 97%; Figure 3 b) over a wide dynamic range (10 1 -10 6 counts). It is possible that the deviation observed at low bacterial counts are due to errors arising from the preparation of spiked-samples. Since the µ Hall system is capable of measuring individual bacteria, the detection limit is ultimately one bacterium.
The µ Hall measurements are robust against biological backgrounds, as the sensing mechanism is based on magnetic interactions. Furthermore, measurements could be performed even in the presence of unbound MNPs. The µ Hall sensors detect magnetic moments arising from a very small volume ( ∼ 10 pL) which contains on average less than 1 unbound MNP (for a particle concentration of 10 8 /mL). Pathogens, in contrast, can have 10 4 -10 6 MNPs per cell, generating a µ Hall signal significantly greater than the background. To test this hypothesis, we compared µ Hall detection of bacteria in both pure buffer (phosphate buffer saline; PBS) and in the presence of excess MNPs (10 9 particles/ml). We confi rmed that Hall voltages from both samples were similar (Figure 3 c) . The slight increase in V H ( ∼ 7%) observed in the presence of excess MNPs is presumed to be the result of longer exposure of bacteria to the MNPs, an effect that could be compensated for in post-data processing. In view of such background insensitivity, direct pathogen detection is possible. This capability signifi cantly simplifi es the assay procedure and minimizes the loss of rare pathogens.
To demonstrate its clinical utility, we applied the µ Hall system to the detection of Gram-positive bacteria. The early diagnosis of such bacteria has become increasingly important with the emergence of drug-resistant strains (e.g., methicillin-resistant S. aureus /MRSA , vancomycin-resistant Enterococci, penicillinresistant Streptococcus pneumoniae ). [20] [21] [22] The following panel of Gram-positive bacteria were tested: S. aureus , Enterococcus faecalis ( E. faecalis ) and Micrococcus luteus ( M. luteus ). As a control group, the following Gram-negative species were used: Klebsiella pneumoniae ( K. pneumoniae ), Moraxella catarrhalis ( M. catarrhalis ), Pseudomonas aeruginosa ( P. aeruginosa ). Samples were prepared by spiking cultured bacteria in liquid media (see Experimental section), which were then labeled with vanc-TCO and fl uorescent MNP-Tz. Although the media contained ample proteins (2% fetal bovine serum and 1 mg/ml bovine serum albumin), we observed little changes in labeling efficiency, which confi rmed the robustness of this bioorthogonal approach. Figure 3 d summarizes the profi ling results. Both the µ Hall sensor and fl ow cytometry were able to reliably distinguish Gram-positive from Gram-negative species. The µ Hall sensor, however, required a far smaller sample volume (1 µ L) than the fl ow cytometer ( ∼ 500 µ L). The µ Hall assay time per sample was ∼ 1 hour (40 minutes for MNP labeling, 30 minutes for µ Hall detection).
In summary, we have developed a new bacterial detection platform, the µ Hall system, for point-of-care diagnosis. By combining recent advances in magnetic nanomaterials and microelectronics, the µ Hall system offers the following key advantages: 1) minimal sample processing and robust detection in different biological backgrounds (e.g., pH, salinity, turbidity); 2) high-throughput detection (10 7 cells/minutes) and high resolution (single cell); and 3) simple and automatic diagnosis using a compact and self-contained device. As a proof-ofprinciple, we demonstrated the system's capability for universal detection of Gram-positive bacteria using vancomycin as the targeting ligand. By using different affi nity ligands, the system could ultimately be adapted to specifi cally detect a variety of different pathogens (e.g., by using antibodies) [ 23 ] and to the more comprehensive detection of bacteria (e.g., by using a Gramstaining equivalent). [ 24 ] Moreover, the µ Hall sensors can be implemented into a monolithic integrated circuit (IC) chip. By incorporating a large number of sensors and control circuits, the IC chip could provide superior throughput and obviate the need for microfl uidics. Such a system would represents a powerful diagnostic tool with signifi cant potential for controlling infectious diseases and promoting public health.
Experimental Section
Fabrication of µ Hall device, magnetic simulation of µ Hall sensing, and preparation of labeling agents : This information is described in the SI Methods. 
